WallStreetZenWallStreetZen

NASDAQ: FENC
Fennec Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for FENC

Based on 2 analysts offering 12 month price targets for Fennec Pharmaceuticals Inc.
Min Forecast
$16.00+109.97%
Avg Forecast
$16.50+116.54%
Max Forecast
$17.00+123.1%

Should I buy or sell FENC stock?

Based on 2 analysts offering ratings for Fennec Pharmaceuticals Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their FENC stock forecasts and price targets.

FENC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Bottom 2%
2
BuyMaintains$17.00+123.10%2023-08-04
Cantor Fitzgerald
Top 26%
75
Strong BuyMaintains$16.00+109.97%2023-04-06

1 of 1

Forecast return on equity

Is FENC forecast to generate an efficient return?
Company
N/A
Industry
0.9%
Market
28.66%

Forecast return on assets

Is FENC forecast to generate an efficient return on assets?
Company
N/A
Industry
0.08%

FENC revenue growth forecast

How is FENC forecast to perform vs Biotechnology companies and vs the US market?
Company
116.15%
Industry
35.79%
Market
8.17%
FENC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
FENC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

FENC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
FENC$7.62$16.50+116.54%Strong Buy
GOSS$0.89$3.83+331.64%Buy
CRMD$3.63$12.33+239.75%Buy
ALXO$4.82$14.00+190.46%Strong Buy
RENB$3.39N/AN/A
View Top Biotech Stocks

Fennec Pharmaceuticals Stock Forecast FAQ

Is Fennec Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: FENC) stock is to Strong Buy FENC stock.

Out of 2 analysts, 1 (50%) are recommending FENC as a Strong Buy, 1 (50%) are recommending FENC as a Buy, 0 (0%) are recommending FENC as a Hold, 0 (0%) are recommending FENC as a Sell, and 0 (0%) are recommending FENC as a Strong Sell.

If you're new to stock investing, here's how to buy Fennec Pharmaceuticals stock.

What is FENC's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: FENC) forecast ROE is N/A, which is considered weak.

What is FENC's Price Target?

According to 2 Wall Street analysts that have issued a 1 year FENC price target, the average FENC price target is $16.50, with the highest FENC stock price forecast at $17.00 and the lowest FENC stock price forecast at $16.00.

On average, Wall Street analysts predict that Fennec Pharmaceuticals's share price could reach $16.50 by Aug 4, 2024. The average Fennec Pharmaceuticals stock price prediction forecasts a potential upside of 116.54% from the current FENC share price of $7.62.

What is FENC's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: FENC) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.08%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.